The Munich-based medical technology company Brainlab is set to launch its initial public offering (IPO) on the Frankfurt Stock Exchange.
According to an announcement made by the company on Thursday, Brainlab plans to list on the regulated market (Prime Standard) in the coming weeks. Through the issuance of new shares, the firm aims to raise up to €200 million, which will be used to expand its business operations. The primary focus will be on broadening the company’s software offerings to additional clinical applications and adjacent market segments, as well as strengthening its balance sheet. Additionally, current shareholders intend to sell part of their holdings to ensure sufficient free float. The IPO is being organized by Berenberg, Deutsche Bank, Commerzbank, Jefferies, and Unicredit, with Evercore providing advisory services to the company.
Brainlab, which employs around 2,000 people, offers medical technology software…
